CHARLES MILITELLO: Open Payments
NPI 1922054808 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 9 payments from 7 companies in 2025. Trend: 2023 $213 · 2024 $87 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| United Therapeutics Corporation | 1 | $18 |
| Baxter Healthcare | 1 | $15 |
| 3B Medical, Inc. | 1 | $7 |
Products named: DUPIXENT, TRELEGY ELLIPTA, OPSUMIT, Tyvaso, Hillrom - Vest System Model 105 Home Care, LUNA.
Industry payments across AZ — which companies pay providers there.
